EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults

Daniel C. Semenza, Christopher Thomas

Criminology · 17.06.2026

DOI: 10.1111/1745-9125.70058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Criminology, online erschienen am 17.06.2026. Verfasst von Daniel C. Semenza und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), a class of medications widely prescribed for diabetes and obesity, have exhibited emerging effects on substance use, reward processing, and impulse control. This study examines whether current GLP‐1 RA use moderates established behavioral pathways to violent crime from impulsivity and alcohol use. Data come from a 2025 nationally representative US survey ( n = 7521; 821 lifetime GLP‐1 RA users). Negative binomial regression models with overlap weighting compared current ( n = 597) and former ( n = 224) users on self‐reported violent criminal behavior in the past year. Although impulsivity and alcohol use were strongly associated with violent criminality, these associations were significantly weaker among current GLP‐1 RA users (GLP‐1 RA × impulsivity incidence rate ratio (IRR) = 0.38, p = 0.002; GLP‐1 RA × alcohol use IRR = 0.48, p = 0.023). Robustness checks consistently supported the GLP‐1 RA × impulsivity interaction, whereas less consistent support was found for the alcohol interaction. Results suggest that GLP‐1 RAs may attenuate widely documented behavioral risk mechanisms like impulsivity linked to aggression, pointing to novel biosocial hypotheses regarding pharmacological influences on violent criminality. Future longitudinal and experimental research should confirm these findings and test causal mechanisms.

Zitieren

APA

Semenza, D. C., & Thomas, C. (2026). Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults. Criminology. https://doi.org/10.1111/1745-9125.70058

Vancouver

Semenza DC, Thomas C. Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults. Criminology. 2026. doi:10.1111/1745-9125.70058

BibTeX
@article{Semenza2026,
  author = {Semenza, Daniel C. and Thomas, Christopher},
  title = {Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults},
  journal = {Criminology},
  year = {2026},
  doi = {10.1111/1745-9125.70058}
}
Kostenlos starten →